HIV

Novel class of inhibitors may be used as a preventive measure for HIV in the future.

Anxiety and depression linked to longer time living with HIV.

A combination of dolutegravir and rilpivirine may reduce pill burden for patients with HIV.

New system could improve the implementation of pre-exposure prophylaxis-based care for HIV prevention.

Although PrEP is highly effective, few appropriate patients with HIV currently use it.

Immersion in HIV/AIDS practice is the best way to understand this infectious disease and keep current with treatment changes.

Long-acting antiretroviral maintains significant viral load reduction and increases CD4+ T cells in HIV.

Findings suggest that human genetics trigger mutations in the HIV viral genome.

A team of researchers from the City University of New York found fewer than 1 in 10 suitable PrEP candidates are currently taking PrEP, in a new article published in Journal of Acquired Immune Deficiency Syndrome.

Mother-to-child transmission rates dropped to 1.9% in 2015.

Antibody that binds to HIV and SIV leads to sustained remission.

Top news of the day from across the health care landscape.

Women with abnormal vaginal microbiota showed no difference in efficacy of daily oral PrEP compared to women with normal vaginal microbiota, according to data presented at the annual Conference on Retroviruses and Opportunistic Infections in Seattle.

Kaiser report finds the ACA played a significant role in the increase of health insurance for HIV-positive patients.

Structural factors impact access to high-quality HIV prevention and care services.

The program comprises 2 studies with over 1000 patients who previously achieved viral suppression on a 3- or 4-drug antiretroviral regimen.

Statistics show condomless sex is on the rise among men who have sex with men.

Association found between medically appropriate food support and improved HIV and diabetes health.

Comprehensive nutrition could improve the overall health of patients with chronic diseases.

Top news of the day from across the health care landscape.

Top news of the day from across the healthcare landscape.

Supporters argue current laws are outdated and single out HIV-positive individuals.

Special patient population produces new broadly neutralizing antibodies to defeat HIV.

Conventional HIV drugs could be transformed into once a month dosing.

Comorbid chronic obstructive pulmonary disorder may be underestimated in patients with HIV.

Treatment with protease inhibitors could result in HIV-associated neurocognitive diseases.

Top articles of the week on Specialty Pharmacy Times.

Manufacturers will present clinical trial results at the upcoming HIV medical meeting.

Gut antibody imbalance may impact immune response to HIV.

For patients with HIV, liver disease is a major cause of morbidity and mortality.